Hantz Financial Services’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $92K | Sell |
329
-13
| -4% | -$3.74K | ﹤0.01% | 1316 |
|
|
2025
Q4 | $104K | Buy |
342
+119
| +53% | +$37.1K | ﹤0.01% | 1126 |
|
|
2025
Q3 | $63K | Buy |
223
+183
| +458% | +$49.8K | ﹤0.01% | 1145 |
|
|
2025
Q2 | $10K | Buy |
40
+31
| +344% | +$7.33K | ﹤0.01% | 1502 |
|
|
2025
Q1 | $2K | Buy |
+9
| New | +$2.71K | ﹤0.01% | 1344 |
|
|
2024
Q1 | – | Sell |
-30
| Closed | -$10K | – | 1197 |
|
|
2023
Q4 | $10K | Hold |
30
| – | – | ﹤0.01% | 802 |
|
|
2023
Q3 | $11K | Sell |
30
-4
| -12% | -$1.54K | ﹤0.01% | 789 |
|
|
2023
Q2 | $13K | Hold |
34
| – | – | ﹤0.01% | 749 |
|
|
2023
Q1 | $16K | Sell |
34
-21
| -38% | -$9.83K | ﹤0.01% | 721 |
|
|
2022
Q4 | $23K | Buy |
55
+52
| +1,733% | +$21K | ﹤0.01% | 664 |
|
|
2022
Q3 | $1K | Hold |
3
| – | – | ﹤0.01% | 1003 |
|
|
2022
Q2 | $1K | Hold |
3
| – | – | ﹤0.01% | 979 |
|
|
2022
Q1 | $2K | Hold |
3
| – | – | ﹤0.01% | 948 |
|
|
2021
Q4 | $2K | Hold |
3
| – | – | ﹤0.01% | 807 |
|
|
2021
Q3 | $2K | Hold |
3
| – | – | ﹤0.01% | 766 |
|
|
2021
Q2 | $2K | Sell |
3
-123
| -98% | -$74.9K | ﹤0.01% | 756 |
|
|
2021
Q1 | $72K | Sell |
126
-10
| -7% | -$5.92K | ﹤0.01% | 507 |
|
|
2020
Q4 | $79K | Sell |
136
-48
| -26% | -$27.3K | ﹤0.01% | 476 |
|
|
2020
Q3 | $95K | Sell |
184
-22
| -11% | -$11.1K | ﹤0.01% | 436 |
|
|
2020
Q2 | $93K | Sell |
206
-113
| -35% | -$49.9K | 0.01% | 414 |
|
|
2020
Q1 | $112K | Buy |
+319
| New | +$117K | 0.01% | 383 |
|
Other funds holding BIO
VCM
VPM
AI
